Search Results
Search this site
79 results found with an empty search
- About Us | CDL
Learn more about Clinical Diagnostic Laboratories, located in Ashburn and Sterling within the Loudoun County area. About Clinical Diagnostic Laboratories Our main goal is to provide an alternative testing facility for individuals: doctors, as well as hospitals that are affordable and convenient. What makes Clinical Diagnostics Laboratories different from the others? We provide excellent service with a personal and friendly touch. We have an on-call Director at the Lab who has a Ph.D. in Pathology. Our Full-time Technologist has over ten years of experience in the Medical Lab field. Clinical Diagnostic Laboratories has grown quickly throughout the area with respect to returning individuals, referrals, and walk-ins because we treat our patients with dignity and respect. Schedule An Appointment Commemorated as Local Heroes to the Community Throughout the years, Clinical Diagnostic Laboratories has worked extensively to provide testing and our services to organizations and government officials regularly to maintain a safe environment for everyone. During the peak of the COVID-19 Pandemic, Clinical Diagnostic Laboratories provided additional assistance to help guarantee the safety of the community. Due to their efforts, they were awarded by Fairfax County with the Community Hero Award. You can read more using the button below. Read More Here One of the Best at What We Do! We help medical facilities, individual patients, large companies, and organizations. Below are a few of the groups we’ve partnered with. View Our Capability Statement What Others Say About Us For over 5 years, our facility has continued to provide excellent, quality service to many patients. Here’s what they say about us and our laboratory. Leave a Review
- Serine Proteinase 3 (PR3) Antibody | Clinical Diagnostic Laboratories
Ordering information regarding a Serine Proteinase 3 (PR3) Antibody for Clinical Diagnostic Laboratories. Serine Proteinase 3 (PR3) Antibody Ordering Recommendation When used in conjunction with other autoantibody tests (ANCA, MPO), may aid in differentiating suspected Wegener granulomatosis (WG) from other vasculitides. May be useful to monitor patients with PR3 antibodies. Panel tests are available. For the workup of suspected vasculitis, refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR3) (3003745 ). For patients with a history of vasculitis, refer to Myeloperoxidase (MPO) Antibody and Serine Proteinase 3 (PR3) Antibody with Reflex to Anti-Neutrophil Cytoplasmic Antibody, IgG by IFA (3003746 ). Mnemonic PR3 Performed Mon-Sat Methodology Semi-Quantitative Multiplex Bead Assay Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.2 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma, urine, or other body fluids. Contaminated, hemolyzed, or severely lipemic specimens., icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 AU/mL or less Negative 20-25 AU/mL 26 AU/mL or greater Equivocal Positive Interpretive Data Approximately 85% of patients with a C-ANCA pattern by IFA have antibodies specific for PR3. Compliance Category: FDA Note CPT Code 83516 Components Component Chart Name Serine Proteinase 3 (PR3) Ab, IgG Component Test Code 0050527 LOINC 6968-2 Aliases PR3 PR3 Ab PR3 IgG Antibodies
- Lipid Panel | Clinical Diagnostic Laboratories
Ordering information regarding a Lipid Panel test for Clinical Diagnostic Laboratories. Lipid Panel Ordering Recommendation Use to assess cardiovascular disease risk and guide therapy. Mnemonic Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Refer to individual components. Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid). Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months Reference Interval Interpretive Data An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease. Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal. CHD Risk Factors +1 Men, 45 years and older +1 Women, 55 years and older or premature menopause without estrogen therapy +1 Family history of premature CHD +1 Current smoking +1 Hypertension +1 Diabetes mellitus +1 Low HDL cholesterol: 39 mg/dL or less -1 High HDL cholesterol: 60 mg/dL or greater Desirable Adult Values Higher Risk Borderline Total Cholestorol Triglycerides 199 mg/dL or less 149 mg/dL or less 200-239 mg/dL 150-199 mg/dL 240 mg/dL or greater 200-499 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 129 mg/dL or less (99 mg/dL or less if patient has CHD) 39 mg/dL or less 130-159 mg/dL 160 mg/dL or greater VLDL Cholesterol (calculated) 30 mg/dL or less Desirable Children & Adolescents Higher Risk Borderline Total Cholestorol 169 mg/dL or less 170-199 mg/dL Triglycerides 149 mg/dL or less 150-199 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 109 mg/dL or less 110-129 mg/dL VLDL Cholesterol (calculated) 30 mg/dL or less 200 mg/dL or greater 200-499 mg/dL 39 mg/dL or less 130 mg/dL or greater Note CPT Code 80061 Components Component Test Code 0020031 0020040 0020051 0020053 0020551 0020705 0020008 0020023 0020024 0020025 0020027 0020029 0020030 0020032 0020396 3004293 Component Chart Name Sodium, Serum or Plasma Potassium, Serum or Plasma Chloride, Serum or Plasma Carbon Dioxide, Serum or Plasma Alkaline Phosphatase Aspartate Aminotransferase Alanine Aminotransferase Urea Nitrogen, Serum or Plasma Glucose, Serum or Plasma Creatinine, Serum or Plasma Calcium, Serum or Plasma Protein Total, Serum/Plasma Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma Anion Gap UH EGFR LOINC 2951-2 2823-3 2075-0 2028-9 6768-6 1920-8 1742-6 3094-0 2345-7 2160-0 17861-6 2885-2 1751-7 1975-2 33037-3 Aliases ACPA Antibody Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC
- Beta-2 Glycoprotein 1 Antibodies, IgG and IgM | Clinical Diagnostic Laboratories
Ordering information regarding Beta-2 Glycoprotein 1 Antibodies, IgG and IgM test for Clinical Diagnostic Laboratories. Beta-2 Glycoprotein 1 Antibodies, IgG and IgM Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Cardiolipin Antibodies, IgG and IgM (0099344 ). May also be useful in estimating risk of thrombosis and/or pregnancy-related morbidity in patients with systemic lupus erythematosus (SLE). Mnemonic B2GPI PAN Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval Reference Interval Components <=20 SGU B2Glycoprotein 1, IgG Antibody <=20 SMU B2Glycoprotein 1, IgM Antibody Interpretive Data The persistent presence of IgG and/or IgM beta 2 glycoprotein I (B2GPI) antibodies is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM B2GPI antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). B2GPI results greater than 20 SGU (IgG) and/or SMU (IgM) are considered positive based on the cutoff values established for this test. International reference materials and consensus units for anti-B2GPI antibodies have not been established (Clin Chim Acta. 2012;413(1-2):358-60; Arthritis Rheum. 2012;64(1):1-10.); results can be variable between different commercial immunoassays and cannot be compared. Strong clinical correlation is recommended for a diagnosis of APS. Low positive IgG and IgM B2GPI antibody levels should be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86146 x2 Components Component Chart Name B2Glycoprotein 1, IgG Antibody Component Test Code 0050322 LOINC 44448-9 0050323 B2Glycoprotein 1, IgM Antibody 44449-7 Aliases Anti-B2-Glycoprotein 1 Anti-B2-Glycoprotein I Anti-B2-GP 1 Anti-B2-GP1 Anti-B2-GPI Anti-beta-2 glycoprotein 1 Anti-beta-2 glycoprotein I Apolipoprotein H Apolipoprotein H, APOH B2 Glycoprotein 1 antibodies B2GP Antibodies B2GP1 B2GPI IgG, IgM BECKY Beta 2 GP1 Ab IgG Beta 2 GP1 Ab IgM Beta 2GP1 Ab Beta 2Glycoprotein 1 Please Also View: Beta-2 GlycoProtein 1 Antibody, igA
- Rheumatoid Factor (RF) | Clinical Diagnostic Laboratories
Ordering information regarding a Rheumatoid Factor (RF) for Clinical Diagnostic Laboratories. Rheumatoid Factor (RF) Ordering Recommendation Aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Consider ordering this test in conjunction with Cyclic Citrullinated Peptide (CCP) Antibody, IgG (0055256 ) to increase specificity and sensitivity. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Quantitative Immunoturbidimetry Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Fasting specimen preferred. Collect: Serum separator tube or plasma separator tube. Also acceptable: Green (lithium heparin), lavender or pink. Specimen Preparation: Allow the specimen to clot completely at room temperature. Transfer 0.5 mL serum or plasma to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or grossly lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 8 days; Frozen: 3 months (should not be thawed more than once) Reference Interval 0-14 IU/mL Interpretive Data Note CPT Code 86431 Components Component Chart Name Rheumatoid Factor Component Test Code 0050465 LOINC 11572-5 Aliases RA RF Rheumatoid Arthritis Factor
- T Uptake| Clinical Diagnostic Laboratories
Ordering information regarding a T- Uptake test for Clinical Diagnostic Laboratories. T Uptake Ordering Recommendation The preferred alternative to this test is Thyroxine, Free (Free T4) Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube or green (lithium heparin). Also acceptable: lavender Specimen Preparation: Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation of cells: Ambient: 8 days; Refrigerated: 2 weeks; Frozen: 2 years Reference Interval Components Available Separately Reference Interval Thyroxine, Total T4 0.8-1.3 TBI Interpretive Data Thyroxine, Free (Free T4) is the preferred test alternative for T Uptake and Free Thyroxine Index tests. Note CPT Code 84479 Components Component Test Code Component Chart Name LOINC 3005979 T Uptake 74795-6 Aliases T3 Uptake T4 uptake, S T4U, Serum TBC THBR Thyroid Binding Ratio Thyroxine-binding capacity Throxine Binding Index Triiodothyronine uptake, serum
- Urea Nitrogen, Serum or Plasma (BUN) | | Clinical Diagnostic Laboratories
Ordering information regarding BUN for Clinical Diagnostic Laboratories. Ammonia, Plasma Ordering Recommendation Screening test to evaluate kidney function. Methodology Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Green (sodium or lithium heparin). Collect on ice. Specimen Preparation: Allow specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to a Standard Transport Tube. (Min: 0.2 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Specimens containing sodium fluoride. Remarks: Stability: After separation from cells: Ambient: 1 week; Refrigerated: 1 week; Frozen: 1 year Reference Interval Refer to Report Interpretive Data Note CPT Code 84520 Components Component Test Code Component Chart Name LOINC 0020023 Urea Nitrogen, Serum or Plasma 3094-0 Aliases Urea Nitrogen Clearance Blood Urea Nitrogen BUN
- HPV Assay Test | Clinical Diagnostic Laboratories
Ordering information regarding a HPV Assay Test for Clinical Diagnostic Laboratories. Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Liquid-Based Pap Test and Hologic Thin Prep Ordering Recommendation This FDA-approved test and platform is designed for primary HPV screening in individuals aged 25 and older with a cervix. It is also FDA-approved for routine cervical cancer screening in combination with cervical cytology (Pap smear) for those aged 30 and older. Additionally, it serves as a follow-up test for abnormal cytology results in individuals aged 21 and older. Mnemonic Methodology Qualitative Polymerase Chain Reaction Performed Mon-Sat Reported Within 1-5 days Specimen Required Patient Preparation: Collect: Cervical, anal, or vaginal specimen with brush or spatula from ThinPrep kit and place in PreservCyt Media Specimen Preparation: Mix well. Transfer 3 mL to a Standard Transport Tube. (Min 1.5 mL). For primary screening purposes, please submit a specimen aliquot and keep the original specimen at the client site. Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Bloody or dark brown specimens. Specimens in any media other than indicated above. Remarks: Specimen source required. Stability: Ambient: 6 months; Refrigerated: 6 months; Frozen: Unacceptable Reference Interval Negative Interpretive Data This test detects the DNA of HPV16, HPV18, and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) that are linked to cervical cancer and its precursor lesions. The accuracy of the results may be influenced by specimen collection methods, the infection stage, and the presence of interfering substances. It's crucial to interpret these results alongside other laboratory and clinical data. A negative high-risk HPV result does not rule out the presence of other high-risk HPV types, potential future cytologic abnormalities, underlying CIN2-3, or cancer. HPV testing is not recommended for the screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under 21 years of age. Note CPT Code 87624 Components Component Chart Name Component Test Code LOINC HPV Source 0060752 31208-2 2011935 HPV Genotype 16 by PCR 77399-4 2011936 2011941 HPV, Other High Risk by PCR 82675-0 HPV Genotype 18 by PCR 77400-0 Aliases HPV High Risk HPV HR ThinPrep HPV Primary screening Human papilloma virus
- Lab Panel Order Schedule an Appointment | Clinical Diagnostic Laboratories
Schedule an appointment for a recently purchased laboratory panel. You're Almost There... Thank you for your purchase! Your order is currently being reviewed by our team, and we’re ready to welcome you at one of our locations. To complete the process, please schedule your lab appointment below. This helps us prepare for your visit and ensures everything is ready for your draw. 📅 Important Notice: Appointments Required 📅 To give our prepaid patients the dedicated time and attention they deserve, we do not accept walk-ins for pre-purchased lab panels. Scheduling ahead helps eliminate confusion, ensures your requested tests are properly prepared, and allows us to serve you promptly and efficiently.
- Double-Stranded DNA (DsDNA) Antibody | Clinical Diagnostic Laboratories
Ordering information regarding a Double-Stranded DNA (DsDNA) Antibody test for Clinical Diagnostic Laboratories. Double-Stranded DNA (DsDNA) Antibody Ordering Recommendation Secondary screening for systemic lupus erythematosus (SLE) based on ANA results. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Indirect Fluorescent Antibody Performed Mon-Sat Reported 1-3 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma. Contaminated, hemolyzed, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month (avoid repeated freeze/thaw cycles) Reference Interval 24 IUs or less Double-Stranded DNA (dsDNA) Ab IgG ELISA Interpretive Data Positivity for anti-double stranded DNA (anti-dsDNA) IgG antibody is a diagnostic criterion of systemic lupus erythematosus (SLE). Specimens are initially screened by enzyme-linked immunosorbent assay (ELISA). If ordered as reflex (0050215), positive ELISA results (>24 IU) will be reflexed to a highly specific IFA titer (Crithidia luciliae indirect fluorescent test [CLIFT]) for confirmation. Some patients with early or inactive SLE may be positive for anti-dsDNA IgG by ELISA but negative by CLIFT. If the patient is negative by CLIFT but positive by ELISA and clinical suspicion remains, consider antinuclear antibody (ANA) testing by IFA. Note If dsDNA IgG antibody is detected, the result will be confirmed by Double-Stranded DNA (dsDNA) Antibody, IgG by IFA (using Crithidia luciliae). Additional charges apply. CPT Code 86225; if reflexed, add 86256 Components Component Chart Name Component Test Code LOINC Double-Stranded DNA (dsDNA) Ab IgG ELISA 0050215 58465-6 Aliases anti-DNA Anti-dsDNA Antibody Anti-Native DNA Antibody to ds-DNA Crithidia luciliae DNA ds Ab Double stranded DNA antibody ds DNA Ab ds-DNA ds-DNA IgG dsDNA reflex dsDNA reflex panel Native double-stranded DNA antibody

